OurMind

Organisation sizes or stages where this product is overkill or insufficient

• Very small practices that primarily need quick dictation cleanup and simple copy/paste notes may find simpler, lower-cost self-serve tools more appropriate.

Industries or use cases where competitors are clearly superior

• US health systems deeply tied to Epic/Cerner may find enterprise vendors with native integrations more turnkey.

Technical requirements that this product may not meet (based on public documentation)

• If procurement requires a publicly documented SOC 2 Type II report.
• If SCIM provisioning, detailed audit logging documentation, or specific encryption/KMS posture must be publicly documented in vendor materials.
• The vendor may support these under NDA or enterprise contracts, but public documentation was not found in this research.

Budget constraints that make alternatives more appropriate

• Organisations that cannot justify a base subscription plus per-user add-ons may prefer single-function scribes or tools with transparent pricing.

Specific workflows or integrations where the product may fall short

• Workflows that require fully automated structured data entry, coding optimization, or deep bidirectional EHR integration should be validated against the vendors current capabilities and roadmap items listed as coming in 2026.

Red flags in the buying process

• Limited independent reviews on major platforms increases the need for pilot validation.
• Lack of transparent base pricing for Notes increases procurement time and negotiation overhead.

Current limitations acknowledged by the vendor

• Public marketing pages do not explicitly enumerate limitations; an Integrations section lists items as coming in 2026, which implies current integration coverage may be incomplete.

Features on the roadmap (not yet available) - note estimated dates if available

• The vendor lists integrations and other items as coming in 2026; no specific months were captured in this research.

Scale limitations (at what volume/size does it break down?)

• Not publicly documented.

Security or compliance gaps

• ISO 27001 and NEN 7510 are stated; SOC 2 and some ISO extensions (27017/27018/27701) are not documented in accessible public sources.

Technical debt or architectural limitations mentioned in reviews

• No OurMind-specific external reviews were found in accessible sources.

API limitations or integration constraints

• The vendor links to API documentation, but the content was not captured in this research; buyers should validate API coverage, rate limits, and EHR integration methods during procurement.

Competitive advantages supported by public signals (not only vendor claims)

• Publicly stated attributes and customer references suggest several differentiators:
  • Claims of clinician involvement in product development.
  • A provider co-ownership claim that is not common in the ambient scribe market.
  • References to Dutch hospitals and compliance with NEN 7510.

Unique features and capabilities reported by the vendor

• A model of provider co-ownership.
• A broader product scope including assistant features and reusable templates beyond note drafting.

Differentiation from competitors based on available public information

• Insufficient independent third-party review coverage exists to fully validate differentiation claims.

Areas where competitors clearly have advantages

• Enterprise incumbents typically provide deeper integration footprints, wider third-party evaluations, and larger deployment case studies.
• Self-serve tools often provide published pricing and abundant peer reviews that reduce procurement friction.

Direct quotes from Gartner Peer Insights, Reddit, TrustRadius, G2, HackerNews

• Gartner Peer Insights: no OurMind product listing/reviews were found in accessible results; Gartner access can be restricted.
• G2: searches surfaced vendors with similar names but not OurMind in accessible results.
• TrustRadius: no OurMind product page/reviews were found in accessible results.
• Reddit: direct OurMind-specific user reviews were not found in accessible results; Reddit contains broader ambient-scribe discourse relevant to evaluating OurMind-type products.
• HackerNews: no clearly relevant OurMind thread was found in accessible results.

Vendor-published testimonials (available; positive skew likely)

• Homepage quote:
  • "Less administration provides the space and energy to innovate further, in order to meet the growing demand for care." — Sander Fidder, pediatrician at Nij Smellinghe Hospital
• Homepage quote:
  • "It already saves me time on longer consultations" — Joost Meuleman, GP & practice owner
• Dutch homepage line (translated):
  • "Through OurMind I can return to the essence of being a GP: genuine attention for the patient." (vendor-published)

Community/peer discourse (ambient scribe category; mixed)

• Common positive outcomes clinicians discuss for ambient scribes (category-level, not OurMind-specific):
  • Time savings and reduced after-hours charting are frequently cited as the main benefit.
• Common negative points clinicians raise (category-level):
  • Some clinicians report ambient scribes do not capture context reliably, particularly with complex patients.
  • Reliability issues are a deal-breaker: if encounters are not consistently captured, clinicians must recreate notes, increasing workload.
  • Patient consent/expectations: some patients may feel uncomfortable learning after the fact that an AI scribe was used.

Why customers chose this product over alternatives (evidence available)

• For OurMind specifically, the clearest differentiators in available sources are:
  • Netherlands/EU fit (GDPR + NEN7510 emphasized)
  • Vendor claims clinician involvement and a provider co-ownership model
  • Integration partnerships such as a Dutch patient communication channel

Why some customers left for competitors (churn reasons)

• No OurMind-specific churn accounts found in accessible sources.
• Category-level churn drivers likely apply:
  • Note quality not reliable enough for specialty needs
  • Integration friction with the EHR
  • Concerns about data rights and vendor policies
  • Pricing expansion as seats/features scale